Global Irritable Bowel Syndrome (IBS) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Irritable Bowel Syndrome (IBS) market size will reach 7,666.66 Million USD in 2025 and is projected to reach 19,817.14 Million USD by 2032, with a CAGR of 14.53% (2025-2032). Notably, the China Irritable Bowel Syndrome (IBS) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by a combination of symptoms, including abdominal pain, bloating, changes in bowel habits, and discomfort. IBS is considered a functional gastrointestinal disorder, meaning there is no structural abnormality or damage to the digestive tract. The exact cause of IBS is not well understood, but factors such as abnormalities in the gut-brain axis, hypersensitivity of the intestines, and changes in gut motility may contribute to its development. IBS can be categorized into different subtypes based on predominant symptoms, such as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or mixed-type (alternating between constipation and diarrhea). Diagnosis is typically based on the presence of characteristic symptoms, and healthcare providers may recommend dietary changes, medications, and lifestyle modifications to manage symptoms. Although IBS can be a chronic condition, it does not lead to serious complications or increase the risk of other gastrointestinal diseases. Management strategies are focused on alleviating symptoms and improving the quality of life for individuals with IBS.
The major global suppliers of Irritable Bowel Syndrome (IBS) include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Irritable Bowel Syndrome (IBS). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Irritable Bowel Syndrome (IBS) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Irritable Bowel Syndrome (IBS) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Irritable Bowel Syndrome (IBS) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Irritable Bowel Syndrome (IBS) Include:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Irritable Bowel Syndrome (IBS) Product Segment Include:
IBS-D Drug
IBS-C Drug
Others
Irritable Bowel Syndrome (IBS) Product Application Include:
Women
Men
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Irritable Bowel Syndrome (IBS) Industry PESTEL Analysis
Chapter 3: Global Irritable Bowel Syndrome (IBS) Industry Porter's Five Forces Analysis
Chapter 4: Global Irritable Bowel Syndrome (IBS) Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Irritable Bowel Syndrome (IBS) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Irritable Bowel Syndrome (IBS) Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Irritable Bowel Syndrome (IBS) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Irritable Bowel Syndrome (IBS) market size will reach 7,666.66 Million USD in 2025 and is projected to reach 19,817.14 Million USD by 2032, with a CAGR of 14.53% (2025-2032). Notably, the China Irritable Bowel Syndrome (IBS) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by a combination of symptoms, including abdominal pain, bloating, changes in bowel habits, and discomfort. IBS is considered a functional gastrointestinal disorder, meaning there is no structural abnormality or damage to the digestive tract. The exact cause of IBS is not well understood, but factors such as abnormalities in the gut-brain axis, hypersensitivity of the intestines, and changes in gut motility may contribute to its development. IBS can be categorized into different subtypes based on predominant symptoms, such as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or mixed-type (alternating between constipation and diarrhea). Diagnosis is typically based on the presence of characteristic symptoms, and healthcare providers may recommend dietary changes, medications, and lifestyle modifications to manage symptoms. Although IBS can be a chronic condition, it does not lead to serious complications or increase the risk of other gastrointestinal diseases. Management strategies are focused on alleviating symptoms and improving the quality of life for individuals with IBS.
The major global suppliers of Irritable Bowel Syndrome (IBS) include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Irritable Bowel Syndrome (IBS). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Irritable Bowel Syndrome (IBS) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Irritable Bowel Syndrome (IBS) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Irritable Bowel Syndrome (IBS) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Irritable Bowel Syndrome (IBS) Include:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Irritable Bowel Syndrome (IBS) Product Segment Include:
IBS-D Drug
IBS-C Drug
Others
Irritable Bowel Syndrome (IBS) Product Application Include:
Women
Men
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Irritable Bowel Syndrome (IBS) Industry PESTEL Analysis
Chapter 3: Global Irritable Bowel Syndrome (IBS) Industry Porter's Five Forces Analysis
Chapter 4: Global Irritable Bowel Syndrome (IBS) Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Irritable Bowel Syndrome (IBS) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Irritable Bowel Syndrome (IBS) Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Irritable Bowel Syndrome (IBS) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Irritable Bowel Syndrome (IBS) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Irritable Bowel Syndrome (IBS) Product by Type
- 1.2.1 IBS-D Drug
- 1.2.2 IBS-C Drug
- 1.2.3 Others
- 1.3 Irritable Bowel Syndrome (IBS) Product by Application
- 1.3.1 Women
- 1.3.2 Men
- 1.4 Global Irritable Bowel Syndrome (IBS) Market Size Analysis (2020-2032)
- 1.5 Irritable Bowel Syndrome (IBS) Market Development Status and Trends
- 1.5.1 Irritable Bowel Syndrome (IBS) Industry Development Status Analysis
- 1.5.2 Irritable Bowel Syndrome (IBS) Industry Development Trends Analysis
- 2 Irritable Bowel Syndrome (IBS) Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Irritable Bowel Syndrome (IBS) Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Irritable Bowel Syndrome (IBS) Market Analysis by Country
- 4.1 Global Irritable Bowel Syndrome (IBS) Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Irritable Bowel Syndrome (IBS) Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.5 China Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.6 France Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.14 India Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Irritable Bowel Syndrome (IBS) Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Irritable Bowel Syndrome (IBS) Market Revenue by Key Suppliers (2021-2025)
- 5.2 Irritable Bowel Syndrome (IBS) Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Irritable Bowel Syndrome (IBS) Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Irritable Bowel Syndrome (IBS) Market Analysis by Type
- 6.1 Global Irritable Bowel Syndrome (IBS) Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Irritable Bowel Syndrome (IBS) Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Bausch Health
- 7.1.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio
- 7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Allergan
- 7.2.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Portfolio
- 7.2.3 Allergan Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Takeda
- 7.3.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Portfolio
- 7.3.3 Takeda Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Sucampo Pharmaceuticals (Mallinckrodt)
- 7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio
- 7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Sebela Pharmaceuticals Inc
- 7.5.1 Sebela Pharmaceuticals Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio
- 7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Astellas Pharmaceuticals
- 7.6.1 Astellas Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio
- 7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
- 8.2 Irritable Bowel Syndrome (IBS) Product Downstream Application Analysis
- 8.2.1 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Irritable Bowel Syndrome (IBS) Revenue and Forecast by Application (2020-2032)
- 8.3 Irritable Bowel Syndrome (IBS) Typical Downstream Customers
- 8.4 Irritable Bowel Syndrome (IBS) Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
